Earnings Release
Park Medi World Q1 FY27 Results: Net Profit Surges 35% YoY to ₹88.6 Crore
NSE
PARKHOSPS
BSE
544645
Park Medi World Limited reported strong Q1 FY27 financial results with revenue growing 19% YoY to ₹4,757 million, EBITDA up 20% YoY to ₹1,261 million, and net profit surging 35% YoY to ₹886 million. Net profit margin expanded 220 basis points to 18.6%. The company is executing its largest-ever capacity expansion, expecting to add 1,490 beds in calendar year 2026 (46% growth), funded through a balance sheet with negligible term debt.
PRICE-SENSITIVE TRIGGER
Event: Q1 FY27 Financial Results Announcement
Type: Earnings Release
Impact: Positive
Immediate Effect: Strong double-digit growth across all key financial metrics; margin expansion; significant capacity addition pipeline; positive sentiment for the stock.

Metrics:
- Revenue from Operations: ₹4,757 million (+19% YoY, +3% QoQ)
- EBITDA (ex-Other Income): ₹1,261 million (+20% YoY, -1% QoQ)
- EBITDA Margin: 26.5% (expansion of 20 bps YoY)
- Net Profit: ₹886 million (+35% YoY, +15% QoQ)
- Net Profit Margin: 18.6% (expansion of 220 bps YoY)
- EPS: ₹2.05 (+20% YoY, +15% QoQ)
- Term Bank Debt: ₹256 million (negligible)
- Fixed Deposits: ₹2,998 million (strong liquidity)
Operating Metrics:
- Total Bed Capacity: 3,960 (+32% YoY, +10% QoQ)
- Occupancy: 55.6% (down 1,224 bps YoY due to capacity addition)
- Total Patients: 249,800 (+17% YoY)
- IPD Patients: 26,300 (+16% YoY)
- OPD Patients: 223,400 (+17% YoY)
Highlight:
- Net Profit Margin expansion of 220 bps YoY to 18.6%, despite significant capacity addition and associated ramp-up costs.
What Happened ?
Park Medi World Limited, North India’s second largest hospital chain, announced its unaudited financial results for the quarter ended June 30, 2026. The company delivered strong year-on-year growth across revenue, EBITDA, and net profit, while simultaneously executing its largest-ever capacity expansion program. The company added significant bed capacity through greenfield and acquisition routes during the quarter.
key details
- Revenue up 19% YoY to ₹4,757 million; EBITDA up 20% YoY to ₹1,261 million.
- Net profit up 35% YoY to ₹886 million; net profit margin expanded 220 bps to 18.6%.
- Commissioned largest-ever greenfield hospital in Panchkula (350 beds) on April 10, 2026.
- Signed definitive agreement to acquire ‘The Medicity Hospital’ in Rudrapur (Kumaon region’s largest NABH-accredited hospital) on May 25, 2026; commissioned on August 2, 2026.
- Subsidiary Umkal Health Care approved 100-bed expansion at Palam Vihar, Gurugram (under ‘Park Platinum’), expected November 2026; will take consolidated Gurugram capacity to 750 beds.
- Signed definitive agreement to acquire ‘Mehar Hospital’ in Zirakpur at ₹107 crore valuation on August 3, 2026; 150+ bed multi-super specialty facility expected November 2026.
- Expects to commission 1,490 beds in calendar year 2026 (46% growth over 2025 capacity of 3,250 beds) – single largest capacity addition in any 12-month period.
- Negligible term debt of ₹256 million; strong liquidity with ₹2,998 million in fixed deposits.
Note:
- Occupancy declined to 55.6% from 67.8% in Q1 FY26 due to significant capacity addition (up 32% YoY) and newly commissioned beds still in ramp-up phase. The company’s near-term focus remains integration of acquired assets and improving utilisation at newer facilities while sustaining profitability.
Risk Analysis
Summary:
- While the company delivered strong financial performance, risks include integration of acquired assets, occupancy ramp-up at new facilities, and execution of the large capacity expansion program.
Key Risks:
- Integration of multiple acquired hospitals (Rudrapur, Zirakpur) could face operational and cultural challenges.
- Occupancy at newly commissioned facilities (Panchkula, Rudrapur, Agra) may take time to ramp up to optimal levels.
- Large-scale capacity addition (1,490 beds in 2026) could strain management bandwidth and operational resources.
- Regulatory changes in healthcare sector or pricing controls could impact margins.
- Intense competition in key markets from other hospital chains.
- Rising manpower and medical equipment costs could pressure margins.
Worst Case:
- Slower-than-expected occupancy ramp-up at new facilities combined with integration challenges could impact profitability and cash flows.
Risk Level: Medium
Company Commentary
Management highlighted that:
- Dr. Ajit Gupta, Chairman, and Dr. Ankit Gupta, Managing Director: “Q1 FY’27 has been a strong start to the year, with Revenue up 19%, EBITDA up 20% and Net Profit up 35% year-on-year, and Net Profit margin expanding 220 basis points to 18.6%. We have delivered this while executing the largest capacity expansion in our history, with newly commissioned beds still ramping up.”
- “With Panchkula, Rudrapur and today’s agreement to acquire Mehar Hospital in Zirakpur, we expect to commission 1,490 beds in calendar year 2026 — a c.46% addition to capacity, funded from a balance sheet carrying negligible term debt.”
- “Our near-term focus remains the integration of acquired assets, improving utilisation at newer facilities, and sustaining profitability while delivering affordable, high-quality healthcare and long-term value for all our stakeholders.”
Official Exchange Filing: Park Medi World Limited


